134,135 It has been approved to deliver anti-sense oligonucleotides for the treatment of spinal muscular atrophy
System X c , the most up-stream node in the ferroptosis signaling cascade (Sato et al., 2018
It is estimated that the glucagon-like peptide-1 (GLP-1) market will exceed US$100 billion (80.3 billion) by 2030, driven equally by diabetes and obesity usage
Right alongside statins and antihypertensives
Critics of GLP-1 therapies often portray those who use these medications as opting for an easy way out to achieve thinness, perpetuating longstanding biases like those historically associated with bariatric surgery (Heitmann, 2025)
The triple agonism gives prescribers a mechanistic rationale for trying retatrutide in plateau cases, but this remains an area requiring individual clinical judgment